Abstract:Background & Aim： Guanylate-binding protein 5 (GBP5) is an essential component of cell-autonomous immune responses against microbial infection. Here we investigated the potential roles for GBP5 in the pathogenesis of inflammatory bowel diseases (IBD) including Crohn's disease (CD) and ulcerative colitis (UC). Method Colon tissues were collected from IBD patients at the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Colitis mice were obtained by feeding male C57BL/6 mice with 2.5% dextran sulfate sodium (DSS) water for 7days. Global gene expression profiles in the colonic mucosa of CD and UC were examined with our microarray dataset GSE16879. Individual gene and protein expression were analyzed by quantitative real-time PCR (qPCR) and Western blot, respectively. Gene enrichment analysis was performed with WEB-based Gene Set Analysis Toolkit (WebGestalt). Immunohistochemistry and three-color immunofluorescence were performed to examine the tissue and cellular localization of GBP5. Three GBP5 specific siRNA were used to transfect THP-1 and Jurkart T cells to investigate the cellular function of GBP5. Result Both immunohistochemistry and immunofluorescence analyses indicated that GBP5 was only expressed in immune cells including T lymphocytes, B lymphocytes and macrophages, in the mucosa and the germinal center of the intestine, More GPB5 positive cells were observed in areas with more severe inflammation from the same patient. Consistently, highly elevated GBP5 expression was observed in the colonic mucosa of IBD patients and DSS induced colitis mice, In addition, the expression level of GBP5 returned to normal levels in the responders after infliximab treatment, but remained elevated in the non-responders (Figure 1). From our transcriptome dataset, genes correlated with GBP5 were identified, and these genes were enriched in myeloid leukocyte activation and immune effector process, In line with this, GBP5 knockdown with siRNA in THP-1 and Jukart T cell line led to the decreased expressions of TNFα, IFNG, IL-8, IL-18, CASP2, NLRP1 and NLRP4 (Figure 2). Discussion Our observations demonstrated that GBP5 participated in IBD pathogenesis, The role of GBP5 in IBD may involve the regulation of immune cells and cytokines, Since GBP5 is a microbial sensor, our study may supply a novel link between the host and gut microbiota in the pathogenesis of IBD. Future effort will use the intestinal gbp5-/- conditional knockout mouse model to define the exact role of GBP5 in IBD.

Interferon inducible guanylate‐binding protein 1 modulates the lipopolysaccharide‐induced cytokines/chemokines and mitogen‐activated protein kinases in macrophages

[Recent Progress in Interferon Induced Protein GBP1 Research].

Guanylate Binding Protein 1 (GBP1): A Key Protein in Inflammatory Pyroptosis

Knockdown of GBP1 Inhibits BCG-induced Apoptosis in Macrophage RAW 264.7 Cells Via P38/jnk Pathway.

Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer

Guanylate Binding Protein 2b Contributes to M1 Macrophage Polarization During Mycobacterium Bovis Infection

Guanylate-binding protein-5 is involved in inflammasome activation by bacterial DNA but only the cooperation of multiple GBPs accounts for control of Brucella abortus infection

Human Guanylate-Binding Protein 1 Positively Regulates Japanese Encephalitis Virus Replication in an Interferon Gamma Primed Environment

LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro

PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection

Guanylate-binding Protein 1 (GBP1) Contributes to the Immunity of Human Mesenchymal Stromal Cells Against Toxoplasma Gondii

Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages

Inducible GBP5 Mediates the Antiviral Response via Interferon-Related Pathways during Influenza A Virus Infection

KLF4 PROMOTES THE EXPRESSION, TRANSLOCATION, AND RELEASE OF HMGB1 IN RAW264.7 MACROPHAGES IN RESPONSE TO LPS

Guanylate-binding protein 5-mediated cell-autonomous immunity suppresses inflammation in dental pulpitis: An in vitro study

Guanylate-binding Protein 1 Participates in Cellular Antiviral Response to Dengue Virus

Role of GBP1 in innate immunity and potential as a tuberculosis biomarker

Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling

Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection

Role of Guanylate‐binding Protein 5 in Colonic Inflammation

Hmgb1 Enhances The Proinflammatory Activity Of Lipopolysaccharide By Promoting The Phosphorylation Of Mapk P38 Through Receptor For Advanced Glycation End Products